Huateng Pharma provides a one stop process development service from concept to commercialization.
SGLT2 Inhibitors
SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Canagliflozin Intermediates
(5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
2-(4-Fluorophenyl)thiophene
Dapagliflozin Intermediates
4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene
Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-
Empagliflozin Intermediates
(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane
(S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene
DPP-4 Inhibitors
DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults.
Sitagliptin Intermediates
3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid
GLP-1 Agonists
GLP-1 agonists are used to lower blood sugar levels to treat diabetes type 2 by releasing more insulin into the bloodstream.
Semaglutide Intermediates
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
tBuO-Ste-Gljavascript:void(0)-OtBu
AEEA-AEEA
CH2COOH-PEG2-NH2.HCl
Boc-NH-PEG2-CH2COOH
Fmoc-NH-PEG2-CH2COOH
NH2-PEG2-CH2COOH
Meet Us In Person
CPhI North America 2023
25-27 April, 2023
Pennsylvania Convention Center, Philadelphia
Booth #322
Request A Meeting
CPhI China 2023
19-21 June, 2023
Shanghai New International Expo Center
Booth #W1D08
Request A Meeting
sales@huatengusa.com
+86 0731 89916275